Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

New HCPCS Modifiers Replace -59 on January 1, 2015

Staff  |  Issue: December 2014  |  December 1, 2014

The following examples show when modifier -59 should be used in accordance with CPT definition; a coding rule has to be met to report a code combination, and modifiers -51 or -50 will not appropriately explain the scenario.

1. A patient is in the office for an infusion, and after 35 minutes and 200 mg of infliximab, the patient has an adverse reaction. The infusion is stopped, and the patient’s IV is flushed with saline for 32 minutes, and diphenhydramine is pushed to counteract the adverse reaction. The infusion is discontinued, and the patient is monitored for 30 minutes. This would be coded as:

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
  • 96413: chemotherapy administration, intravenous infusion technique; up to one hour, single or initial substance/drug;
  • 96375: each additional sequential intravenous push of a new substance/drug (list separately in addition to code for primary procedure); and
  • 96361-59: since only one initial code is allowed per session, modifier -59 will have to be appended to allow reimbursement for the hydration. Usually, the hydration would be bundled with the main procedure, but it is allowed if the saline is used to flush the line in the case of an adverse reaction.

>> With the new -X modifiers, this visit would be billed as follows:

  • 96413;
  • 96375; and
  • 96361-XU: Unusual Non-Overlapping Service: the use of a service that is distinct because it does not overlap usual components of the main service.

2. A 55-year-old female patient with rheumatoid arthritis is seen in the office for a follow-up visit. During the visit, the patient complains of severe swelling and pain in her right shoulder as well as her left knee. The rheumatologist performs a Level 3 office visit and injects the right shoulder and the left knee joint on the same day. (Both procedures are defined by CPT code 20610.) How would this be coded?

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
  • 99213-25: outpatient office visit with a detailed examination and medical decision making with moderate complexity;
  • 20610-RT: aspiration of the right shoulder; and
  • 20610-59/LT: injection of the left knee.

Modifier -59 is the correct modifier to use because it not only indicates a separate site, but also meets the rule, “when a more descriptive modifier will not explain the circumstances, then modifier -59 is used.”

>> With the new -X modifiers, this visit would be billed as follows:

  • 99213-25;
  • 20610-RT; and
  • 20610-XS: Separate Structure: a service that is distinct because it was performed on a separate organ/structure.

Keep in mind for the joint injection that this will not have any effect on when a physician performs a joint injection to a major joint (20610) and a joint injection to an intermediate joint (20605) during the same session. By definition, these two codes are standalone codes; their descriptions identify them as two separate anatomic locations and no specific coding rules must be met (other than documentation and medical necessity), and both are subject to the multiple procedure payment reduction.

Next Steps

Inaccurate or inappropriate use of modifier -59 can and has generated overpayments, incorrect coding and increased audits. As a reminder, modifier -59 should be used only if no other modifier more appropriately describes the relationship(s) of the two or more procedure codes. It’s vital for rheumatology practices to take time to review their coding to ensure they use one of the more descriptive -X modifiers when it is required. If it is necessary to use modifier -59, there will need to be clear and concise documentation to properly reflect that modifier -59 is being used appropriately. Also, these new -X modifier requirements are from CMS, and there is no indication if they will be accepted by commercial payers.

Page: 1 2 3 | Single Page
Share: 

Filed under:Billing/CodingPractice Support Tagged with:AC&RAmerican College of Rheumatology (ACR)BillingCodingdrugHCPCSinfliximabMedicareModifierPracticerheumatologistrheumatology

Related Articles
    Prepare NOW for ICD-10 Medical Coding Transition

    Prepare NOW for ICD-10 Medical Coding Transition

    July 14, 2015

    The ICD-10 page on the Centers for Medicare & Medicaid Services (CMS) website features a countdown clock that shows the time left until Oct. 1, 2015, the date on which compliance with the new code set becomes mandatory. By the time this issue goes to press, the clock will read 90 or fewer days. Time…

    Coding Corner Answer: A Quiz on Modifiers

    February 18, 2019

    Take the challenge. 1. A—Modifier -25 is defined as a significant, separately identifiable evaluation and management (E/M) service by the same physician or other qualified healthcare professional on the same day of the procedure or other service. It is to be placed on the E/M visit only because it attests to the payer there is…

    Coding Corner Question

    July 1, 2010

    July’s Coding Challenge

    Key Facts on Billing Drug Wastage

    January 24, 2023

    The ACR has compiled guidelines and tips on how to use the JW modifier and correctly bill Medicare for discarded drugs and biologicals. This modifier can be applied only to unused amounts from a single-dose vial or package.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences